Lupus Nephritis Clinical Trials in New Orleans, Louisiana

3 studies are recruiting for lupus nephritis in New Orleans, Louisiana right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

    This is a single-arm, open-label, multicenter, ascending dose Phase 1 study evaluating the safety and preliminary efficacy of CTX112 in adult subjects with refractory autoimmune diseases, including active systemic lupus erythematosus (SLE), systemic sclerosis (SSc), or idiopathic inflammatory myopa…

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    Tulane University Medical Center, New Orleans, Louisiana
    Locations
    16 in total
    Run by
    CRISPR Therapeutics

    See if you can join NCT06925542 on ClinicalTrials.gov

  2. Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

    The overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment.

    Stage
    Phase 2
    Ages
    18 to 100
    Site
    Ochsner Health System, New Orleans, Louisiana
    Locations
    103 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT05268289 on ClinicalTrials.gov

  3. A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

    This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Nkarta Investigational Site, New Orleans, Louisiana
    Locations
    19 in total
    Run by
    Nkarta, Inc.

    See if you can join NCT06557265 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.